Pre-erythrocytic malaria vaccine: Mechanisms of protective immunity and human vaccine trials

Parassitologia

Volumn 41, Issue 1-3, 1999, Pages 397-402

  Nardin, E ^a   Zavala, F ^a   Nussenzweig, V ^a   Nussenzweig, R S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; Cs protein; Cytotoxic epitopes; Maps; Polyoximes; Pre erythrocytic malaria vaccine; T helper cells

Indexed keywords

GAMMA INTERFERON; MALARIA VACCINE; PROTOZOON ANTIBODY;

ANIMAL; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REVIEW;

ANIMALS; ANTIBODIES, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; CLINICAL TRIALS; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MALARIA VACCINES; MICE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 0033182171     PISSN: 00482951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH (1997). Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo. Identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein J Immunol 159 1362-1373.
2. Clyde DF (1985) Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 24: 397-401
3. de Oliveira GA, Clavijo P, Nussenzweig RS, Nardin EH (1994). Immunogenicity of an alum absorbed synthetic multiple antigen peptide system based on B and T cell epitopes of the Plasmodium falciparum CS protein, possible vaccine application Vaccine 12: 1012-1017.
4. Ferreira A, Schofield L, Enea V, Schellekens H, van der Meide P, Collins WE, Nussenzweig RS, Nussenzweig V (1986) Inhibition of development of EEF of malaria parasites by gamma interferon Science 232: 881-884.
5. Gwadz RW, Cochrane AH, Nussenzweig V, Nussenzweig RS (1979) Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of P. knowlesi and characterization of surface antigens of these parasites Bull Wld Hlth Org 57, Suppl: 165-173
6. Hollingdale MR, Nardin EH, Tharavanij S, Schwartz A, Nussenzweig RS (1984) Inhibition of entry of Plasmodium falciparum and Plasmodium vivax sporozoites into cultured cells: An in vitro assay of protective antibodies. J Immunol 132: 909-913
7. Jahiel R, Vilcek J, Nussenzweig RS (1970). P. berghei malaria: protection with exogenous interferon Nature 227: 1350-1351.
8. Lalvani A, Hurt N, Aidoo M, Kibatala P, Tanner M, Hill AV (1996). Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. Eur J Immunol 4: 773-779.
9. Li S, Rodrigues M, Rodrigues D, Rodriguez JR, Esteban M, Palese P, Nussenzweig RS, Zavala F (1993). Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T cell-mediated protective immunity against malaria Proc Natl Acad Sci USA 90: 5214-5218
10. Menard R, Sultan AA, Cortes C, Altszuler R, van Dijk MR, Janse CJ, Waters AP, Nussenzweig RS, Nussenzweig V (1997) Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes Nature 385: 336-340.
11. Miyahira Y, Garcia-Sastre A, Rodriguez D, Rodriguez JR, Tsuji M, Murata K, Palese P, Esteban M, Zavala F, Nussenzweig RS (1998) Recombinant viruses expressing a human malaria antigen can elicit potentially protective CD8+ immune responses in mice Proc Natl Acad Sci USA 95: 3954-3959
12. Moreno A, Clavijo P, Davis J, Edelman R, Sztein M, Herrington D. Nardin E (1991) Cytotoxic CD4+ cells from a sporozoite-immunized volunteer recognize the P falciparum CS protein. Int Immunol 3 997-1003
13. Moreno A, Clavijo P, Edelman R, Davis J, Sztein M, Sinigaglia FA, Nardin E (1993). CD4+ T cell clones obtained from Plasmodium falciparum sporozoite immunized volunteers recognize polymorphic sequences of the circumsporozoite protein J Immunol 151: 489-499
14. Moreno A, Rodrigues R, de Oliveira G, Ferreira V, Nussenzweig RS, Moya-Castro ZR, Calvo-Calle JM, Nardin EH (1999). Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice. Vaccine 18: 89-99
15. Munesinghe, DY, Clavijo P, Caivo MC, Nussenzweig RS, Nardin E (1991). Immunogenicity of multiple antigen peptides (MAPs) containing T and B cell epitopes located within the repeat region of the P. falciparum circumsporozoite protein. Eur J Immunol 12, 1015-1020
16. Murata K, Garcia-Sastre A, Tsuji M, Rodrigues M, Rodriguez D, Rodriguez JR, Nussenzweig RS, Palese P, Esteban M, Zavala F (1996) Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol 173: 96-107.
17. Nardin EH, Calvo-Calle JM, de Oliveira GA, Clavijo P, Nussenzweig R, Simon R, Zheng W, Rose K (1998) Plasmodium falciparum polyoximes, highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B cell epitopes and a universal T cell epitope of CS protein. Vaccine 16: 590-600.
18. Nardin EH, Herrington DA, Levine M, Stuber D, Takas B, Caspers P, Barr PJ, Altszuler R, Clavijo P, Nussenzweig RS (1989). Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science 246: 1603-1606
19. Nardin EH, Nussenzweig RS, McGregor IA, Bryan JH (1979). Antibodies to sporozoites: their frequent occurrence in individudals living in an area of hyperendemic malaria. Science 206: 597-599
20. Nardin EH, Nussenzweig V Nussenzweig RS, Collins WE, Harinasuta KT, Tapchaisri P, Chomcharn Y (1982). Circumsporozoite (CS) proteins of human malaria parasites and Plasmodium falciparum and P vivax. J Exp Med 156: 20-30.
21. Nussenzweig RS, Vanderberg J, Most H (1969). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. III. Specificity of the protection. Nature 222 488-489.
22. Nussenzweig RS, Vanderberg J, Orton C, Most H (1967). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216: 160-162.
23. Nussenzweig V, Nussenzweig RS (1985). Circumsporozoite proteins of malaria parasites Cell 42: 401-403.
24. Potocnjak P, Yoshida N, Nussenzweig RS, Nussenzweig V (1980) Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med 151: 1504-1513
25. Robson KJH, Frevert U, Reckmann I, Cowan G, Beier J, Scragg IG, Takehara K, Bishop DHL, Pradel G, Sinden R, Saccheo S, Muller H-M, Crisanti A (1995) Thrombospondin related adhesive protein (TRAP) of Plasmodium falciparum expression during sporozoite ontogeny and aggregate dependent binding to hepatocyte. EMBO J 14: 3883-3894
26. Rodrigues MM, Cordey AS, Arreaza G, Corradin G, Romero PJ, Marianski J, Nussenzweig RS, Zavala F (1991). CD8+ cytolytic T cell clones directed against the P. yoelii circumsporozoite protein protect against malaria Int Immunol 3: 579-586.
27. Rodrigues MM, Nussenzweig RS, Romero P, Zavala F (1992) The in vivo cytotoxic activity of CD8+ T cell clones correlates with their expression of adhesion molecules. J Exp Med 175: 895-905.
28. Romero P, Maryanski JL, Corradin G, Nussenzwieg RS, Nussenzweig V, Zavala F (1989). Cloned cytotoxic T-cells recognize an epitope in the circumsporozoite (CS) protein and protect against malaria. Nature 341: 323-326
29. Rose K, Zeng W, Brown LE, Jackson DC (1995). A synthetic peptide-based polyoxime vaccine construct of high purity and activity. Mol Immunol 32: 1031-1037
30. Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, Hannan CM, Backer M, Sinden R, Smith GL, Hill AVS (1998). Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med 4: 397-402.
31. Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig RS, Nussenzweig V (1987) Gamma-interferon, CD8+ T-cells, and antibodies required for immunity to malaria sporozoites. Nature 330: 664-666
32. Sidjanski SP, Vanderberg JP, Sinnis P (1997). Anopheles Stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum. Mol Biochem Parasitol 90: 33-41.
33. Sinnis P, Ciavijo P, Fenyo D, Chait BT, Cerami C, Nussenzweig V (1994). Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med 180: 297-306
34. Stickl H, Hochstein-Mintzel V, Mayr A, Huber H, Schafer Ch, Holzner A (1974) MVA vaccination against smallpox: clinical trials of an attenuated live vaccinia virus strain (MVA). Dtsch Med Wochenschr 99: 2386-2392
35. Stoute JA, Slaqui M, Heppner DG, Momm P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U, Marchand M, Ballou WR, Cohen JE (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 336: 86-91.
36. Sultan AA, Thathy V, Frevert U, Nussenzweig V, Nussenzweig RS, Menard R (1997) The TRAP protein is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell 90: 511-522.
37. Tam JP, Ciavijo P, Lu Y, Nussenzweig V, Nussenzweig R, Zavala F (1990) Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med 171 299-306
38. Yoshida N, Potocnjak P, Aikawa M, Nussenzweig V, Nussenzweig RS (1980) Hybndoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207: 71-73.
39. Zavala F, Cochrane A, Nardin EH, Nussenzweig RS, Nussenzweig (1983). Circumsporozoite protein of malaria parasites contain a single immunodominant region with two or more identical epitopes J Exp Med 157: 1947-1957